Chemical Component Summary | |
---|---|
Name | LCL-161 |
Synonyms | N-[(1S)-1-cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl]-N~2~-methyl-L-alaninamide |
Identifiers | (2~{S})-~{N}-[(1~{S})-1-cyclohexyl-2-[(2~{S})-2-[4-(4-fluorophenyl)carbonyl-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxidanylidene-ethyl]-2-(methylamino)propanamide |
Formula | C26 H33 F N4 O3 S |
Molecular Weight | 500.629 |
Type | NON-POLYMER |
Isomeric SMILES | C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2c3nc(cs3)C(=O)c4ccc(cc4)F)NC |
InChI | InChI=1S/C26H33FN4O3S/c1-16(28-2)24(33)30-22(17-7-4-3-5-8-17)26(34)31-14-6-9-21(31)25-29-20(15-35-25)23(32)18-10-12-19(27)13-11-18/h10-13,15-17,21-22,28H,3-9,14H2,1-2H3,(H,30,33)/t16-,21-,22-/m0/s1 |
InChIKey | UFPFGVNKHCLJJO-SSKFGXFMSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 68 |
Chiral Atom Count | 3 |
Bond Count | 71 |
Aromatic Bond Count | 11 |
Drug Info: DrugBank
DrugBank ID | DB12085 |
---|---|
Name | LCL-161 |
Groups | investigational |
Description | LCL161 has been used in trials studying the treatment of Leukemia, Neoplasms, Solid Tumors, Breast Cancer, and Ovarian Cancer, among others. |
Synonyms |
|
Categories |
|
CAS number | 1005342-46-0 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL2431768 |
PubChem | 24737642 |
ChEMBL | CHEMBL2431768 |